156 related articles for article (PubMed ID: 30335242)
1. Immediate versus delayed breast reconstruction in breast cancer patients in Colombia: A costutility analysis.
Perea AH; Rosselli D
Biomedica; 2018 Sep; 38(3):363-378. PubMed ID: 30335242
[TBL] [Abstract][Full Text] [Related]
2. COST-UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS, COMPARED WITH ON-DEMAND TREATMENT, FOR PATIENTS WITH SEVERE HEMOPHILIA TYPE A IN COLOMBIA.
Castro Jaramillo HE; Moreno Viscaya M; Mejia AE
Int J Technol Assess Health Care; 2016 Jan; 32(5):337-347. PubMed ID: 27919309
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of Breast Reconstruction Options in the Setting of Postmastectomy Radiotherapy Using the BREAST-Q.
Razdan SN; Cordeiro PG; Albornoz CR; Ro T; Cohen WA; Mehrara BJ; McCarthy CM; Disa JJ; Pusic AL; Matros E
Plast Reconstr Surg; 2016 Mar; 137(3):510e-517e. PubMed ID: 26910695
[TBL] [Abstract][Full Text] [Related]
4. Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia.
Parise H; Espinosa R; Dea K; Anaya P; Montoya G; Ng DB
Pharmacoecon Open; 2020 Mar; 4(1):79-90. PubMed ID: 31168754
[TBL] [Abstract][Full Text] [Related]
5. Is Single-Stage Prosthetic Reconstruction Cost Effective? A Cost-Utility Analysis for the Use of Direct-to-Implant Breast Reconstruction Relative to Expander-Implant Reconstruction in Postmastectomy Patients.
Krishnan NM; Fischer JP; Basta MN; Nahabedian MY
Plast Reconstr Surg; 2016 Sep; 138(3):537-547. PubMed ID: 27556599
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of four common surgical treatment pathways for breast cancer.
Kouwenberg CAE; Mureau MAM; Kranenburg LW; Rakhorst H; de Leeuw D; Klem TMAL; Koppert LB; Ramos IC; Busschbach JJ
Eur J Surg Oncol; 2021 Jun; 47(6):1299-1308. PubMed ID: 33349523
[TBL] [Abstract][Full Text] [Related]
7. A Cost-Utility Analysis Comparing Immediate Oncoplastic Surgery with Delayed Oncoplastic Surgery in Smoking Breast Cancer Patients.
Bloom JA; Asban A; Tian T; Sekigami Y; Losken A; Chatterjee A
Ann Surg Oncol; 2021 May; 28(5):2579-2588. PubMed ID: 33051741
[TBL] [Abstract][Full Text] [Related]
8. Cost-utility analysis of an implantable cardioverterdefibrillator for the treatment of patients with ischemic or non-ischemic New York Heart Association class II or III heart failure in Colombia.
Atehortúa S; Senior JM; Castro P; Ceballos M; Saldarriaga C; Giraldo N; Mora G
Biomedica; 2019 Sep; 39(3):502-512. PubMed ID: 31584764
[TBL] [Abstract][Full Text] [Related]
9. A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer.
Chatterjee A; Asban A; Jonczyk M; Chen L; Czerniecki B; Fisher CS
Am J Surg; 2019 Sep; 218(3):597-604. PubMed ID: 30739739
[TBL] [Abstract][Full Text] [Related]
10. A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with single stage implant reconstruction in the treatment of breast cancer.
Asban A; Homsy C; Chen L; Fisher C; Losken A; Chatterjee A
Breast; 2018 Oct; 41():159-164. PubMed ID: 30099327
[TBL] [Abstract][Full Text] [Related]
11. [Cost-effectiveness of consolidation treatments for acute myeloid leukemia in high-risk pediatric patients within the Colombian healthcare system].
García M; Chicaíza LA; Quitián H; Linares A; Ramírez Ó
Biomedica; 2015; 35(4):549-56. PubMed ID: 26844444
[TBL] [Abstract][Full Text] [Related]
12. Combining vascularized lymph node transfer with autologous breast reconstruction: A Surveillance, Epidemiology and End Results (SEER) Database cost-utility analysis.
Corkum JP; Bezuhly M
J Plast Reconstr Aesthet Surg; 2020 Oct; 73(10):1879-1888. PubMed ID: 32536463
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia.
Mejía A; Senior JM; Ceballos M; Atehortúa S; Toro JM; Saldarriaga C; Mejía ME; Ramírez C
Biomedica; 2015; 35(4):531-40. PubMed ID: 26844442
[TBL] [Abstract][Full Text] [Related]
14. Comparing five alternative methods of breast reconstruction surgery: a cost-effectiveness analysis.
Grover R; Padula WV; Van Vliet M; Ridgway EB
Plast Reconstr Surg; 2013 Nov; 132(5):709e-723e. PubMed ID: 24165623
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of resource costs and success rates between immediate and delayed breast reconstruction using DIEP or SIEA flaps under a well-controlled clinical trial.
Cheng MH; Lin JY; Ulusal BG; Wei FC
Plast Reconstr Surg; 2006 Jun; 117(7):2139-42; discussion 2143-4. PubMed ID: 16772907
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Pediatric Cochlear Implantation in Rural China.
Qiu J; Yu C; Ariyaratne TV; Foteff C; Ke Z; Sun Y; Zhang L; Qin F; Sanderson G
Otol Neurotol; 2017 Jul; 38(6):e75-e84. PubMed ID: 28379918
[TBL] [Abstract][Full Text] [Related]
17. Lifetime Costs of Prophylactic Mastectomies and Reconstruction versus Surveillance.
Mattos D; Gfrerer L; Reish RG; Hughes KS; Cetrulo C; Colwell AS; Winograd JM; Yaremchuk MJ; Austen WG; Liao EC
Plast Reconstr Surg; 2015 Dec; 136(6):730e-740e. PubMed ID: 26595028
[TBL] [Abstract][Full Text] [Related]
18. Cost comparison of immediate one-stage and tissue-expander breast reconstructions after mastectomy in commercially insured patients.
Singh NK; Reaven NL; Funk SE
Manag Care; 2013 Mar; 22(3):36-43. PubMed ID: 23610805
[TBL] [Abstract][Full Text] [Related]
19. Comparing the cost of delayed and immediate autologous breast reconstruction in Belgium.
Neyt MJ; Blondeel PN; Morrison CM; Albrecht JA
Br J Plast Surg; 2005 Jun; 58(4):493-7. PubMed ID: 15897033
[TBL] [Abstract][Full Text] [Related]
20. Cost-utility and budget impact analysis of CPAP therapy compared to no treatment in the management of moderate to severe obstructive sleep apnea in Colombia from a third-party payer perspective.
Robles A; Gil-Rojas Y; Amaya D; Hernández F; Escobar-Cordoba F; Venegas M; Amado S; Restrepo-Gualteros S; Echeverry J; Marín F; Zabala S; Bazurto-Zapata MA; Deger M
Expert Rev Pharmacoecon Outcomes Res; 2023 Apr; 23(4):399-407. PubMed ID: 36852713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
